SCHEMBL6550118

SCHEMBL6550118

CCCCCCCCCCCCCCCC(=O)OC(Cc1ccccc1C=CC(=O)O)CN1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.50
UGCG Q16739 3/20 0.44
ESR1 P03372 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
MAPK1 P28482 2/20 0.38
CYP2C19 P33261 2/20 0.38
MAPT P10636 2/20 0.38
TP53 P04637 1/20 0.38
CYP2C9 P11712 1/20 0.38
NFKB1 P19838 1/20 0.38
HIF1A Q16665 1/20 0.38
MTOR P42345 1/20 0.38
LMNA P02545 2/20 0.38
GMNN O75496 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6550112 1.00 GAA (0.50) GAAUGCGESR1MEN1KMT2A
SCHEMBL6550122 0.77 GAA (0.51) GAAUGCGMEN1KMT2ACYP3A4
SCHEMBL6548344 0.75 MAPT (0.49) MEN1KMT2ACYP2D6MAPK1MAPT
SCHEMBL6548347 0.75 MAPT (0.49) MEN1KMT2ACYP2D6MAPK1MAPT
SCHEMBL17832884 0.74 GAA (0.67) GAAMEN1KMT2ACYP2D6MAPK1
SCHEMBL23001192 0.69 GAA (0.60) GAAUGCGMEN1KMT2ACYP2D6
SCHEMBL17817115 0.69 GAA (0.60) GAAUGCGMEN1KMT2ACYP2D6
SCHEMBL17817112 0.69 GAA (0.60) GAAUGCGMEN1KMT2ACYP2D6
SCHEMBL3250731 0.69 PTGER3 (0.54) MAPT
SCHEMBL489896 0.69 PTGER3 (0.54) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115697-B1 UNSATURATED HYDROXIMIC ACID DERIVATIVES AS PARP INHIBITORS GENE KUTATO KFT N (HU) 2004-02-04 EP disclosed
US-6500823-B1 ENERGY DEFICIENCY OF THE CELL CAUSED BY PARP INHIBITION, IN DIABETES COMPLICATIONS, IN OXYGEN DEFICIENT STATUS OF THE HEART AND BRAIN, IN NEURODEGENERATIVE DISEASES, IN THE TREATMENT OF AUTOIMMUNE AND/OR VIRAL DISEASES N-GENE RESEARCH LABORATORIES, INC. 2002-12-31 US disclosed
EP-1115697-A1 UNSATURATED HYDROXIMIC ACID DERIVATIVES AS PARP INHIBITORS N-Gene Kutato KFT. (HU) 2001-07-18 EP disclosed
WO-2000014054-A1 UNSATURATED HYDROXIMIC ACID DERIVATIVES AS PARP INHIBITORS N-Gene Kutató Kft. (HU) 2000-03-16 WO disclosed